Ceapro Inc V.CZO

cash into 2025?

[fossi_2002]

AEZS Juli 13, 2023

"Based on our current projections, we believe the Company has the ability to meet its currently anticipated cash needs into 2025."

So if AEZS runs out of money in 2025, where will the money for PGX come from?
The only way is through a capital increase.

[Tencents]

Or diagnostic or pgx upfront or something' But management has to indicate what plans are in place

[Ciao]

As they already stated, if the merger goes through, they will consolidate shares of the new company on the basis of 1 for 3 (or 4) to assure NASDAQ eligibility for min. share price requirements. So the 15M shares of the new company would become say 4 - 5 M shares.  Then they could raised $50M by offering 10M shares at say $5/share. That's another 100% dilution. The last share offering of

[prophetoffactz]

 

[lscfa]

I wish these damn drug development co.s were forced to do PEAs like the resource industry to disclose the expected capex needed for phases 1,2,3 trials and marketing costs when commercialized.

[prophetoffactz]

H.C. Wainwright has a US$15 price target for AEZS likely supported by a discounted cashflow analysis. The merged company should support more analysts. A NASDAQ listing and a US$100 million market cap should attract a whole new level of interest. Research Capital and Bloom Burton were used for the merger. With pediatric approval for the diagnostic, and 100L PGX scale-up and commercial licensing

[tigerpro]

There is no way they can do capital increase in the future.  Nobody believes them anymore. The management team has lost their credit.     After merge,  bankruptcy after 2025 is the only possible result for the new company.   Without merge, CZO's CEO will lose his job after this year's annual shareholder meeting. He knows this very well.  After

[tigerpro]

The merge will be harmful for both companies' shareholders.  The merge is only good for the executive managers of both companies(they can keep their jobs, nobody can easily vote them out in the annual shareholder meeting).  The best method for shareholders:    Vote No first, then For CZO,   change CEO during this year's annul shareholder meeting; For